EU increases support to vaccine production in Rwanda as first mRNA facility opens. “Marking the inauguration today of the first BioNTech Africa manufacturing site in Kigali, Rwanda, the European Union has increased its Global Gateway investments in the country under the Team Europe Initiative on manufacturing and access to vaccines, medicines and health technologies in Africa (MAV+).” Read more on the European Commission website.
With this new contribution the total Team Europe support to local manufacturing and access to vaccines, medicines and health technologies in Rwanda comes to €93.7 million.
European Commission President Ursula von der Leyen and President Paul Kagame witnessed the signature of a €40 million financial agreement. Investments include nurturing local research and development, fostering biotech start-ups, and building up the surrounding talent pool. With this new contribution the total Team Europe support to local manufacturing and access to vaccines, medicines and health technologies in Rwanda comes to €93.7 million.
Shout-out to TEI MAV+ partners. “The European Union and Team Europe, encompassing Germany, Belgium, France, Lithuania, Sweden, Austria and the European Investment Bank, have partnered with Rwanda to strengthen the local ecosystem for vaccines and medicines manufacturing and health resilience.”